What is vitamin B2 good for? The honest answer

Quail eggs in a wooden bowl on a dark surface, a food source of vitamin B2 riboflavin

Vitamin B2 is riboflavin. Its job is to become two coenzymes, FMN and FAD, which dozens of enzymes need in order to work. Those enzymes release energy from food, recycle your main antioxidant, generate the active form of vitamin B6, and convert tryptophan into niacin. Vitamin B2 is mostly useful for what it switches on.

Which makes it the least interesting vitamin on any label, and the one most likely to be quietly limiting the rest. In 407 healthy adults aged 18 to 92, 37% had deficient riboflavin status on the standard functional test, and their levels of active vitamin B6 tracked downwards with it regardless of how much B6 they were eating (Jungert et al., Journal of Nutrition, 2020).

The short version

  • Vitamin B2 becomes FMN and FAD, the coenzymes that run energy metabolism.
  • It generates the active form of vitamin B6 and powers the folate enzyme MTHFR.
  • 37% of 407 healthy adults tested deficient on the functional biomarker.
  • Men need about 1.3mg a day in the UK, women 1.1mg.
  • Milk, eggs, mushrooms and plain yoghurt are the main food sources.

What vitamin B2 actually does

Riboflavin arrives from food and gets phosphorylated into flavin mononucleotide (FMN), and most of that goes on to become flavin adenine dinucleotide (FAD). Enzymes carrying one of these are called flavoproteins, and there are dozens of them. They sit in the electron transport chain, in the pathway that burns fat for fuel, and in the recycling loop that keeps glutathione in its working form.

In English: riboflavin sits inside the machinery that burns your fuel.

That last flavoprotein, glutathione reductase, is the basis of the test used to measure riboflavin status. It is called the erythrocyte glutathione reductase activation coefficient, or EGRac, and it works by taking the enzyme from your red blood cells and seeing how much it perks up when FAD is added back. A big response means the enzyme was running short. A systematic review of 18 supplementation trials confirmed EGRac responds reliably to changes in riboflavin intake (Hoey et al., American Journal of Clinical Nutrition, 2009).

The same review made a point worth holding onto: the cutoff that defines deficiency is contested. Every prevalence figure in this post depends on where somebody drew that line.

Vitamin B2 activates your other B vitamins

This is the part that rarely makes the label copy.

Vitamin B6 has to be converted into pyridoxal 5-phosphate (PLP) before it does anything, and the enzyme that performs the conversion runs on FMN. In the 407-adult study, plasma PLP fell in steps as riboflavin status worsened, from optimal (EGRac 1.26 or lower) to low (1.27 to 1.39) to deficient (1.40 or higher), and the pattern held after adjusting for how much vitamin B6 people were eating (P = 0.001). The authors concluded that riboflavin may be the limiting nutrient for maintaining vitamin B6 status, particularly in older people (Journal of Nutrition, 2020). If you have read our piece on vitamin B6 deficiency symptoms, this is the layer underneath it.

Folate runs into the same dependency. MTHFR, the enzyme that produces the methylated folate your cells use, carries FAD as its cofactor. Converting tryptophan into niacin needs a flavin-dependent enzyme as well, which is why a prolonged riboflavin shortfall can produce a secondary niacin shortfall on top of it (StatPearls, Riboflavin Deficiency).

There is a neat consequence here. Buy a B-complex in the pre-activated forms and you skip the riboflavin-dependent conversion step, because the work was already done in the factory. Buy the cheap forms and your riboflavin status becomes the bottleneck. Most labels never tell you which situation you are in.

Riboflavin, MTHFR and blood pressure

The MTHFR connection produced the most interesting riboflavin research of the last twenty years. Around one in ten people in the UK and Ireland carry two copies of the C677T variant in the MTHFR gene, and in some populations worldwide it reaches 32% (McAuley et al., Proceedings of the Nutrition Society, 2016). The variant produces a less stable enzyme, and a less stable enzyme holds onto its FAD cofactor less tightly. Give those people extra riboflavin and the enzyme works better.

A randomised trial at Ulster tested that idea in 91 treated hypertensive adults with the 677TT genotype. Sixteen weeks of riboflavin at 1.6mg a day produced a systolic blood pressure treatment effect of 5.6 mmHg (P = 0.033). Diastolic did not move (P = 0.291). More than 60% of these patients had failed to reach 140/90 while taking multiple blood pressure drugs (Wilson et al., Hypertension, 2013). A four-year follow-up of an earlier cohort, in which 31 people with the TT genotype crossed over between riboflavin and placebo, found systolic down 9.2 mmHg (P = 0.001) and diastolic down 6.0 mmHg (P = 0.003) (Wilson et al., American Journal of Clinical Nutrition, 2012).

Read that carefully before getting excited. These are small trials, in one genotype, run largely by one research group. The 2016 review puts the effect across trials at 5 to 13 mmHg systolic and says the work still needs replicating in other populations and at doses above 1.6mg a day. It applies only if you carry two copies of the variant, and almost nobody has been genotyped. Riboflavin is not a blood pressure medicine and neither is any daily supplement. What it does illustrate is how much of the MTHFR story sits outside folate.

The migraine dose is 300 times the daily requirement

The other genuine standalone finding is migraine. In a 1998 randomised trial, 55 patients took either 400mg of riboflavin a day or placebo for three months. The proportion improving by at least 50% on headache days was 59% on riboflavin against 15% on placebo (P = 0.002), with a number needed to treat of 2.3. Two minor side effects occurred in the riboflavin group, diarrhoea and increased urination (Schoenen et al., Neurology, 1998).

400mg is roughly 300 times the UK daily figure. That is a pharmacological dose that happens to use a vitamin, and no daily supplement carries it. Ours does not either.

What a shortfall looks like

Severe riboflavin deficiency has a name, ariboflavinosis, and a recognisable clinical picture:

  • Cracks and sores at the corners of the mouth
  • Cracked, chapped lips
  • A sore, smooth, red tongue
  • Greasy, scaling skin, often around the nose
  • Sore throat and general mouth discomfort
  • Sensitivity to light
  • Anaemia, with the fatigue that goes with it

That version is mostly diagnosed in low-income countries (StatPearls, Riboflavin Deficiency). The version seen in high-income countries is subclinical, meaning it shows up as a number on a lab test rather than as a symptom you would ever connect to your diet.

The anaemia link has been measured outside low-income settings. Among 206 Canadian and 210 Malaysian women aged 19 to 45, biochemical riboflavin deficiency was present in 40% of the Canadians and 71% of the Malaysians, and deficient women were about twice as likely to be anaemic (adjusted odds ratio 2.38, 95% CI 1.08 to 5.27). The authors described riboflavin status as a weak but significant predictor of haemoglobin, and suggested correcting it might play a small protective role (Aljaadi et al., Journal of Nutrition, 2019). Small is their word.

How much vitamin B2 you need, and where it comes from

The NHS puts adult requirements at about 1.3mg a day for men and 1.1mg for women, aged 19 to 64, and notes that riboflavin cannot be stored, so it has to arrive daily. The main food sources are milk, eggs, fortified breakfast cereals, mushrooms and plain yoghurt (NHS, B vitamins and folic acid).

One quirk worth knowing: UV light destroys riboflavin, which is why the NHS advises keeping those foods out of direct sunlight. The clear glass milk bottle was a small nutritional own goal.

On safety, no upper limit has been set. Absorption is capped, and intakes up to 400mg a day for at least three months have produced no adverse effects (StatPearls, Vitamin B2 (Riboflavin)). The surplus leaves in your urine, which is what turns it fluorescent yellow an hour after a multivitamin. That colour tells you your kidneys are doing their job and nothing more.

What Fireblood puts in

10mg of riboflavin 5-phosphate. That is the phosphorylated form, so it starts one step further along than plain riboflavin, and it comes to roughly eight times the UK figure for men. Which sounds excessive until you factor in the absorption ceiling and the one-hour elimination half-life (StatPearls, Vitamin B2 (Riboflavin)), at which point it mostly means the day is covered.

Now the honest part. If you drink milk and eat eggs most days, you are probably not riboflavin deficient, and 10mg will not change how you feel. There is also a wrinkle worth owning: the vitamin B6 in Fireblood arrives as P5P and the folate as L-5-MTHF, both pre-converted, so neither of those two needs riboflavin to become usable. Riboflavin does that same work on the vitamin B6 and folate in your food, which is where most of your intake comes from, and on the 184mg of L-tryptophan in the formula that can be routed towards niacin.

Riboflavin will never be the headline nutrient. It turns your urine yellow and then it is gone, which is about as unglamorous as biochemistry gets. But every active-form claim printed on a supplement label quietly assumes you have enough of it, and no label has ever said so.

Fireblood contains 10mg of riboflavin as riboflavin 5-phosphate, alongside 38 other nutrients, each one printed on the label with its form and its dose. The full formula is here if you want to hold it up against whatever you are taking now.